EPILEPSY is the most common serious brain disorder worldwide with no age, racial, social class, or geographic boundaries. There are 3.4 million people in the US living with active epilepsy. That’s more than Autism Spectrum Disorders, Parkinson’s, Multiple Sclerosis and Cerebral Palsy combined. Yet, epilepsy receives one-tenth the research funding of any of these other neurological disorders.
THE ROW FOUNDATION is working to improve the quality of training, diagnosis and treatment available to people with epilepsy and associated psychiatric disorders in under-resourced areas of the world, including some in the United States. To date our projects have included:
- Grant to Epilepsy Health Management for improvements to telehealth office space
- Medication grant to Epilepsy Foundation of North Carolina for patient emergencies
- Emergency medication aid to Puerto Rico after Hurricane Maria
- Ongoing medication grants to Epilepsy Foundation North/Central Illinois for patient emergencies
Our largest US grant of $910,000 in medication was recently made to Americares for use in their domestic programs. Americares is a disaster relief and global health organization providing immediate response to emergency medical needs
URGENT NEED
We are seeking a partner to fully fund EEG equipment for a pediatric hospital in Africa whose existing unit is broken beyond repair. This is a critical tool in their treatment of children with brain disorders. To learn more, please contact Lori Hairrell at lori.hairrell@rowpharma.org
